Jim Simons Rigel Pharmaceuticals Inc Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.12 - $1.57 $786,200 - $1.1 Million	701,965 Added 53.25%	2,020,191 $2.99 Million
Q4 2023 Feb 13, 2024	BUY	$0.72 - $1.56 $134,208 - $290,784	186,400 Added 16.47%	1,318,226 $1.91 Million
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.39 $480,751 - $624,527	-449,300 Reduced 28.42%	1,131,826 $1.22 Million
Q2 2023 Aug 11, 2023	SELL	$1.12 - $1.82 $445,303 - $723,617	-397,592 Reduced 20.09%	1,581,126 $2.04 Million
Q1 2023 May 12, 2023	BUY	$1.25 - $2.0 $1.48 Million - $2.36 Million	1,180,218 Added 147.8%	1,978,718 $2.61 Million
Q4 2022 Feb 13, 2023	SELL	$0.67 - $11.9 $339,506 - $6.03 Million	-506,726 Reduced 38.82%	798,500 $1.2 Million
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $1.03 Million - $11.5 Million	940,726 Added 258.09%	1,305,226 $1.54 Million
Q2 2022 Aug 12, 2022	BUY	$0.67 - $3.19 $99,227 - $472,439	148,100 Added 68.44%	364,500 $412,000
Q1 2022 May 13, 2022	BUY	$2.22 - $3.45 $319,236 - $496,110	143,800 Added 198.07%	216,400 $647,000
Q4 2021 Feb 11, 2022	BUY	$2.36 - $3.57 $171,336 - $259,182	72,600 New	72,600 $192,000
Q2 2021 Aug 13, 2021	SELL	$3.09 - $4.54 $681,345 - $1 Million	-220,500 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$3.35 - $4.93 $6.26 Million - $9.21 Million	-1,868,114 Reduced 89.44%	220,500 $754,000
Q4 2020 Feb 10, 2021	SELL	$2.35 - $3.74 $3.04 Million - $4.83 Million	-1,291,800 Reduced 38.21%	2,088,614 $7.31 Million
Q3 2020 Nov 13, 2020	SELL	$1.78 - $4.13 $4.34 Million - $10.1 Million	-2,437,269 Reduced 41.89%	3,380,414 $8.11 Million
Q2 2020 Aug 13, 2020	BUY	$1.41 - $2.05 $2.27 Million - $3.3 Million	1,608,560 Added 38.22%	5,817,683 $10.6 Million
Q1 2020 May 14, 2020	BUY	$1.27 - $3.0 $1.56 Million - $3.7 Million	1,232,183 Added 41.39%	4,209,123 $6.57 Million
Q4 2019 Feb 13, 2020	BUY	$1.6 - $2.43 $1.73 Million - $2.63 Million	1,082,302 Added 57.12%	2,976,940 $6.37 Million
Q3 2019 Nov 13, 2019	BUY	$1.63 - $2.62 $2.88 Million - $4.62 Million	1,763,838 Added 1348.5%	1,894,638 $3.54 Million
Q2 2019 Aug 12, 2019	SELL	$2.02 - $2.61 $995,710 - $1.29 Million	-492,926 Reduced 79.03%	130,800 $341,000
Q1 2019 May 14, 2019	BUY	$2.0 - $2.65 $1.25 Million - $1.65 Million	623,726 New	623,726 $1.6 Million

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account